# Hanover Insurance Group, Inc.: overview

THG · NYSE · CIK 944695 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/thg.md) · [Financials](/companies/thg/financials.md) · [Filings](/companies/thg/filings.md) · [Insiders](/companies/thg/insiders.md)

Latest reported revenue: [$1.73bn](/filings/0000944695-26-000014.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Jul 29, 2026 (XBRL us-gaap:Revenues, accession 0000944695-26-000014).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,565](/filings/0001193125-25-258501.md) | [1,584 d](/filings/0001193125-26-060983.md) | [1,603](/filings/0001193125-26-197530.md) | [1,654](/filings/0000944695-26-000014.md) | [1,665](/filings/0001193125-25-258501.md) | [1,672 d](/filings/0001193125-26-060983.md) | [1,701](/filings/0001193125-26-197530.md) | [1,726](/filings/0000944695-26-000014.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [9.6%](/filings/0001193125-25-258501.md) | [16.1% d](/filings/0001193125-26-060983.md) | [11.6%](/filings/0001193125-26-197530.md) | [12.7%](/filings/0000944695-26-000014.md) | [14.9%](/filings/0001193125-25-258501.md) | [17.3% d](/filings/0001193125-26-060983.md) | [14.7%](/filings/0001193125-26-197530.md) | [14.6%](/filings/0000944695-26-000014.md) |
| Net margin | % | [6.5%](/filings/0001193125-25-258501.md) | [10.6% d](/filings/0001193125-26-060983.md) | [8.0%](/filings/0001193125-26-197530.md) | [9.5%](/filings/0000944695-26-000014.md) | [10.7%](/filings/0001193125-25-258501.md) | [11.9% d](/filings/0001193125-26-060983.md) | [11.0%](/filings/0001193125-26-197530.md) | [11.1%](/filings/0000944695-26-000014.md) |
| Diluted EPS | $ per share | [2.80](/filings/0001193125-25-258501.md) | not reported | [3.50](/filings/0001193125-26-197530.md) | [4.30](/filings/0000944695-26-000014.md) | [4.90](/filings/0001193125-25-258501.md) | not reported | [5.20](/filings/0001193125-26-197530.md) | [5.38](/filings/0000944695-26-000014.md) |
| Free cash flow | $m | [392 d](/filings/0001193125-25-258501.md) | [211 d](/filings/0001193125-26-060983.md) | [37.1](/filings/0001193125-26-197530.md) | [205 d](/filings/0000944695-26-000014.md) | [551 d](/filings/0001193125-25-258501.md) | [377 d](/filings/0001193125-26-060983.md) | [115](/filings/0001193125-26-197530.md) | [209 d](/filings/0000944695-26-000014.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [5,228](/filings/0000950170-24-018917.md) | [5,469](/filings/0000950170-25-025093.md) | [5,994](/filings/0001193125-26-060983.md) | [6,237](/filings/0001193125-26-060983.md) | [6,594](/filings/0001193125-26-060983.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [8.3%](/filings/0000950170-24-018917.md) | [5.2%](/filings/0000950170-25-025093.md) | [1.8%](/filings/0001193125-26-060983.md) | [10.4%](/filings/0001193125-26-060983.md) | [14.1%](/filings/0001193125-26-060983.md) |
| Net margin | % | [8.1%](/filings/0000950170-24-018917.md) | [2.1%](/filings/0000950170-25-025093.md) | [0.6%](/filings/0001193125-26-060983.md) | [6.8%](/filings/0001193125-26-060983.md) | [10.0%](/filings/0001193125-26-060983.md) |
| Diluted EPS | $ per share | [11.60](/filings/0000950170-24-018917.md) | [3.21](/filings/0000950170-25-025093.md) | [0.98](/filings/0001193125-26-060983.md) | [11.70](/filings/0001193125-26-060983.md) | [18.16](/filings/0001193125-26-060983.md) |
| Free cash flow | $m | [816](/filings/0000950170-24-018917.md) | [705](/filings/0000950170-25-025093.md) | [350](/filings/0001193125-26-060983.md) | [796](/filings/0001193125-26-060983.md) | [1,170](/filings/0001193125-26-060983.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/thg/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $756.5m | 3,532,932 |  | Reduced −148,234 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $411.0m | 1,919,628 |  | Reduced −12,832 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $348.4m | 1,627,020 |  | Reduced −4,402 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $312.3m | 1,458,761 |  | Added +6,406 |
| [AQR CAPITAL MANAGEMENT LLC](/funds/1167557.md) | 2026-06-30 | $287.2m | 1,341,075 |  | Added +327,680 |
| [FULLER & THALER ASSET MANAGEMENT, INC.](/funds/1082327.md) | 2026-06-30 | $233.3m | 1,089,705 |  | Added +99,868 |
| [AMERICAN CENTURY COMPANIES INC](/funds/748054.md) | 2026-06-30 | $230.8m | 1,078,105 |  | Added +75,578 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $220.7m | 1,030,544 |  | Added +60,367 |
| [FIRST TRUST ADVISORS LP](/funds/1125816.md) | 2026-06-30 | $176.5m | 824,257 |  | Reduced −3,063 |
| [ALLIANCEBERNSTEIN L.P.](/funds/1109448.md) | 2026-06-30 | $157.6m | 909,130 |  | Added +77,585 |

## Recent filings

[All 1,865 filings](/companies/thg/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-28 | 17:17 ET | [8-K](/filings/0000944695-26-000019.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000944695-26-000019 |
| 2026-07-29 | 17:02 ET | [10-Q](/filings/0000944695-26-000014.md) | Quarterly report, period 2026-06-30 | 0000944695-26-000014 |
| 2026-07-28 | 16:52 ET | [8-K](/filings/0000944695-26-000012.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000944695-26-000012 |
| 2026-07-15 | 17:13 ET | [8-K](/filings/0001193125-26-304948.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-304948 |
| 2026-05-13 | 16:12 ET | [8-K](/filings/0001193125-26-221636.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-221636 |
| 2026-04-30 | 16:33 ET | [10-Q](/filings/0001193125-26-197530.md) | Quarterly report, period 2026-03-31 | 0001193125-26-197530 |
| 2026-04-29 | 17:26 ET | [8-K](/filings/0001193125-26-192352.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-192352 |
| 2026-03-26 | 06:22 ET | [DEF 14A](/filings/0001193125-26-125009.md) | Proxy statement, period 2026-05-12 | 0001193125-26-125009 |
| 2026-02-20 | 13:43 ET | [10-K](/filings/0001193125-26-060983.md) | Annual report, period 2025-12-31 | 0001193125-26-060983 |
| 2026-02-04 | 18:35 ET | [8-K](/filings/0001193125-26-036103.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-036103 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001193125-26-060983.md), filed Feb 20, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, locked when the 8-K was accepted. It is scored when the 10-Q or 10-K is ingested. [See the target](/leagues/2026q3/targets/e56bb8d3-77b8-459c-943b-b23cd62fbedd)

## About the filer

- CIK: 944695
- Tickers: THG
- Exchange: NYSE
- SIC code: 6331 Fire, Marine & Casualty Insurance
- State of incorporation: DE
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 29, 2026, 16:20 ET. No prices; not investment advice.